Percutaneous Auricular Nerve Stimulation for Treating Post-COVID Fatigue (PAuSing-Post-COVID Fatigue)

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:3 publications

Grant number: COV-LT2-0022

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $896,252
  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Newcastle upon Tyne
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Fatigue is a very common symptom of Long COVID. Feedback from patients has highlighted the devastating impact of post-Covid Fatigue (pCF) on lives as well as the need for novel therapeutic options. Interventions that enhance existing therapies and empower those suffering with pCF to manage their own treatment at home are particularly needed. People with the rare disease, primary Sjögren s syndrome, also show fatigue. We previously demonstrated in such people that non-invasive vagus nerve stimulation (nVNS) at the neck delivered twice daily for 26 days significantly reduced fatigue symptoms. Here, we will extend this work to test whether nVNS can reduce fatigue in adults with pCF. The vagus nerve has a branch which supplies the skin around the ear canal. Stimulating the ear can be easily and safely self-administered at home using a handheld battery-powered transcutaneous electrical nerve stimulation (TENS) device, available over the counter without prescription. We will focus on people diagnosed with COVID19 but not requiring hospital in-patient treatment. In this study, 96 participants with pCF will be randomly assigned to one of three study groups. One group will asked to stimulate the part of the ear containing the vagus nerve. For comparison, the other two groups will either be asked to stimulate a part of the ear that does not contain the vagus, or given an electrode that is inactive. After 8 weeks, changes in fatigue severity will be measured using questionnaires and wearable technologies. We will also use lab-based tests to measure changes in brain circuits. From week 9, all participants will switch to receive nVNS until week 16 and the above measurements repeated.

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Recovery of neurophysiological measures in post-COVID fatigue: a 12-month longitudinal follow-up study.

Long COVID: mechanisms, risk factors and recovery.